APA-viite (7. p.)

Brierley, C., Staves, J., Roberts, C., Johnson, H., Vyas, P., Goodnough, L., & Murphy, M. (2019). The effects of monoclonal anti‐CD47 on RBCs, compatibility testing, and transfusion requirements in refractory acute myeloid leukemia. Wiley.

Chicago-viite (17. p.)

Brierley, CK, J. Staves, C. Roberts, H. Johnson, P. Vyas, LT Goodnough, ja MF Murphy. The Effects of Monoclonal Anti‐CD47 on RBCs, Compatibility Testing, and Transfusion Requirements in Refractory Acute Myeloid Leukemia. Wiley, 2019.

MLA-viite (9. p.)

Brierley, CK, et al. The Effects of Monoclonal Anti‐CD47 on RBCs, Compatibility Testing, and Transfusion Requirements in Refractory Acute Myeloid Leukemia. Wiley, 2019.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.